These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16814926)

  • 1. Application of paclitaxel-eluting metal mesh stents within the pig ureter: an experimental study.
    Liatsikos EN; Karnabatidis D; Kagadis GC; Rokkas K; Constantinides C; Christeas N; Flaris N; Voudoukis T; Scopa CD; Perimenis P; Filos KS; Nikiforidis GC; Stolzenburg JU; Siablis D
    Eur Urol; 2007 Jan; 51(1):217-23. PubMed ID: 16814926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of zotarolimus-eluting metal stent in animal ureters.
    Kallidonis P; Kitrou P; Karnabatidis D; Kyriazis I; Kalogeropoulou C; Tsamandas A; Apostolopoulos DJ; Vrettos T; Liourdi D; Spiliopoulos S; Al-Aown A; Scopa CD; Liatsikos E
    J Endourol; 2011 Oct; 25(10):1661-7. PubMed ID: 21905851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coated v noncoated ureteral metal stents: an experimental model.
    Liatsikos EN; Siablis D; Kalogeropoulou C; Karnabatidis D; Triadopoulos A; Varaki L; Zabakis P; Perimenis P; Barbalias GA
    J Endourol; 2001 Sep; 15(7):747-51. PubMed ID: 11697409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of paclitaxel-eluting metal stents in renal artery of pig model.
    Voudoukis T; Liatsikos EN; Kagadis GC; Christeas N; Flaris N; Katsanos K; Costantinides C; Perimenis P; Scopa CD; Filos KS; Nikiforidis GC; Alexopoulos D; Siablis D
    J Endourol; 2007 Dec; 21(12):1571-6. PubMed ID: 18044994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a new polytetrafluoroethylene-covered metallic stent to a noncovered stent in canine ureters.
    Chung HH; Lee SH; Cho SB; Park HS; Kim YS; Kang BC; Frisoli JK; Razavi MK
    Cardiovasc Intervent Radiol; 2008; 31(3):619-28. PubMed ID: 18214599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ureteral metal stents: a tale or a tool?
    Liatsikos EN; Kagadis GC; Barbalias GA; Siablis D
    J Endourol; 2005 Oct; 19(8):934-9. PubMed ID: 16253054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant ureteral obstruction: preliminary results of treatment with metallic self-expandable stents.
    Flueckiger F; Lammer J; Klein GE; Hausegger K; Lederer A; Szolar D; Tamussino K
    Radiology; 1993 Jan; 186(1):169-73. PubMed ID: 8416559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
    Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
    J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New bioabsorbable polylactide ureteral stent in the treatment of ureteral lesions: an experimental study.
    Lumiaho J; Heino A; Tunninen V; Ala-Opas M; Talja M; Välimaa T; Törmälä P
    J Endourol; 1999 Mar; 13(2):107-12. PubMed ID: 10213104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
    Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
    Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a dissolvable ureteral drainage stent in a Swine model.
    Auge BK; Ferraro RF; Madenjian AR; Preminger GM
    J Urol; 2002 Aug; 168(2):808-12. PubMed ID: 12131372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.
    Bangalore S; Amoroso N; Fusaro M; Kumar S; Feit F
    Circ Cardiovasc Interv; 2013 Aug; 6(4):378-90. PubMed ID: 23922145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of in vitro urine flow in single and tandem stented ureters subject to extrinsic ureteral obstruction.
    Dror I; Harris T; Kalchenko V; Shilo Y; Berkowitz B
    Int J Urol; 2022 Oct; 29(10):1221-1226. PubMed ID: 35649584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
    Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
    N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
    J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
    De Luca G; Dirksen MT; Spaulding C; Kelbaek H; Schalij M; Thuesen L; van der Hoeven B; Vink MA; Kaiser C; Musto C; Chechi T; Spaziani G; Díaz de la Llera LS; Pasceri V; Di Lorenzo E; Violini R; Cortese G; Suryapranata H; Stone GW;
    Arch Intern Med; 2012 Apr; 172(8):611-21; discussion 621-2. PubMed ID: 22529227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study.
    Futamatsu H; Sabaté M; Angiolillo DJ; Jimenez-Quevedo P; Corros C; Morikawa-Futamatsu K; Alfonso F; Jiang J; Cervinka P; Hernandez-Antolin R; Macaya C; Bass TA; Costa MA
    J Am Coll Cardiol; 2006 Sep; 48(6):1139-45. PubMed ID: 16978996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.